Insider Transactions in Q3 2024 at Neuroone Medical Technologies Corp (NMTC)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2024
|
Steve Mertens Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,158
-0.66%
|
$0
$0.99 P/Share
|
|
Sep 30
2024
|
Mark Christianson Business Development Director |
SELL
Payment of exercise price or tax liability
|
Direct |
343
-0.12%
|
$0
$0.99 P/Share
|
|
Sep 30
2024
|
David A Rosa CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
4,697
-0.41%
|
$0
$0.99 P/Share
|
|
Aug 31
2024
|
Steve Mertens Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
252
-0.14%
|
$0
$0.8 P/Share
|
|
Aug 31
2024
|
Mark Christianson Business Development Director |
SELL
Payment of exercise price or tax liability
|
Direct |
90
-0.03%
|
$0
$0.8 P/Share
|
|
Aug 31
2024
|
David A Rosa CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,239
-0.19%
|
$0
$0.8 P/Share
|
|
Aug 01
2024
|
Paul Buckman Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,778
+20.31%
|
$0
$0.81 P/Share
|
|
Jul 31
2024
|
Steve Mertens Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
252
-0.14%
|
$0
$0.75 P/Share
|
|
Jul 31
2024
|
Mark Christianson Business Development Director |
SELL
Payment of exercise price or tax liability
|
Direct |
90
-0.03%
|
$0
$0.75 P/Share
|
|
Jul 31
2024
|
David A Rosa CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,239
-0.19%
|
$0
$0.75 P/Share
|